8.73BMarket Cap1.99P/E (TTM)
10.850High10.780Low280.78KVolume10.810Open10.840Pre Close3.04MTurnover0.08%Turnover RatioLossP/E (Static)805.85MShares13.24052wk High1.43P/B3.83BFloat Cap6.97052wk Low--Dividend TTM353.39MShs Float16.760Historical High--Div YieldTTM0.65%Amplitude2.520Historical Low10.810Avg Price1Lot Size
Roivant Sciences Stock Forum
Ph2 readouts in Q1 2024...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
Upcoming Ph 2 readouts in Q1 2024…
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
ColumnsWall Street Today | Bill Ackman Cashes Out Bet Against Treasury Bonds as Yields Hit 16-year Highs
Bill Ackman Cashes Out Bet Against Treasury Bonds as Yields Hit 16-year Highs
One of Wall Street's most prominent bond bears has decided to walk away with his gains, declaring that Treasury yields are likely poised for a turnaround following an ascent that rattled global markets.
Pershing Square's Bill Ackman said Monday that he has closed his bet against 30-year Treasury bonds, saying in a ser...
Loading this
News
ColumnsWeekly Insider Money Tracking: IMVT director undertook a $58 million buy, and AAPL executives sold over $64 million in stocks.
One of $Immunovant(IMVT.US)$'s directors and more than 10% owner, $Roivant Sciences(ROIV.US)$, recently undertook a vast buy transaction worth $58 million. IMVT stock has gained over 104% since the start of this year. It is worth mentioning that Immunovant is a subsidiary of Roivant Sci...
ColumnsWall Street Today | US Consumer Confidence Drops to a Four-Month Low
US Consumer Confidence Drops to a Four-Month Low
US consumer confidence slumped to a four-month low in September, dampened by a deteriorating economic and labor market outlook. The Conference Board’s index declined to 103 this month from an upwardly revised 108.7 in August, data out Tuesday showed. The figure fell short of the median estimate of 105.5 in a Bloomberg survey of economists.
Expectations that reflect consumer...
No comment yet